Anzeige
Mehr »
Freitag, 23.01.2026 - Börsentäglich über 12.000 News
Gold vor 5.000-USD-Marke: Über 2 Mio. Unzen Gold - und trotzdem erst 63 Mio. USD Börsenwert?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C7NS | ISIN: GB00B3TQCK30 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
INSTEM PLC Chart 1 Jahr

Aktuelle News zur INSTEM

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.12.25Instem Unveils New Global Headquarters in Boston, MA276A Bold Step Reflecting Customer Obsession, Strategic Growth, and a New Era for Instem Instem, a global leader in SaaS solutions for life sciences R&D, today announced the official opening of its...
► Artikel lesen
INSTEM Aktie jetzt für 0€ handeln
09.10.25Climb's Innovation Continues at Instem269Advancing Non-GLP In Vivo Research with Speed, Flexibility, and Scientific Focus Following Instem's recent acquisition of RockStep Solutions and their non-GLP study management solution Climb, momentum...
► Artikel lesen
17.07.25Instem Announces Provantis 12: A Powerful Step Forward in Preclinical Study Management285Instem is proud to announce the upcoming launch of Provantis 12, the most advanced on-cloud version yet of its flagship preclinical study management platform. This release includes significant feature...
► Artikel lesen
20.05.25Instem Announces Acquisition of Strong Tower Solutions, Strengthening its Clinical SCE Solutions247Instem is excited to announce that it has closed on an acquisition of Strong Tower Solutions, a technology-enabled service provider with nearly 20 years of configuring and installing qualified, validated...
► Artikel lesen
17.04.25Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution361Following the FDA's recent announcement expanding flexibility in preclinical submission evidence, Instem is reaffirming its role as the industry's trusted provider of an end-to-end preclinical platform...
► Artikel lesen
5 Nachrichten in den letzten 12 Monaten